Ranitidine Hydrochloride and Yondelis

• Generic Name: ranitidine
• Dosage Forms: n.a.
• Other Brand Names: Zantac

Short-term treatment of active duodenal ulcer (endoscopically or radiographically confirmed).

Maintenance of healing and reduction in recurrence of duodenal ulcer.

Long-term treatment of Zollinger-Ellison syndrome, systemic mastocytosis, postoperative hypersecretion, “short-gut” syndrome.

Short-term treatment of active benign gastric ulcer.

Maintenance of healing and reduction in recurrence of gastric ulcer.

Treatment of GERD to achieve acid suppression, control symptoms, and prevent complications.

Treatment of erosive esophagitis (endoscopically diagnosed) in patients with GERD.

Maintain healing and decrease recurrence of erosive esophagitis.

Self-medication as initial therapy for less severe symptomatic GERD.

Short-term self-medication for treatment of heartburn (pyrosis) symptoms associated with acid indigestion and sour stomach in adults and adolescents ≥12 years of age.

Short-term self-medication for prevention of heartburn symptoms associated with acid indigestion and sour stomach brought on by ingestion of certain foods and beverages in adults and children ≥12 years of age.

May be useful for increasing gastric pH in neonates (<1 month of age) at risk for GI hemorrhage during ECMO.

• Generic Name: trabectedin
• Dosage Forms: injection, powder, lyophilized, for solution
• Other Brand Names: Yondelis

Yondelis (trabectedin) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Yondelis is used to treat liposarcoma, a rare type of cancer that grows in fatty tissues of the body.

Yondelis is also used to treat leiomyosarcoma, a rare fast-growing type of cancer that grows in many tissues of the body, including fat, muscle, bone, joints, and blood vessels.

Yondelis is used to treat cancer that has spread to other parts of the body or cannot be treated with surgery.